Home / Import refusals / SCS-7544364-9/11/1

FDA Import Refusal SCS-7544364-9/11/1 — Apotex Corp.

Apotex Corp. — FEI 3006727872

The FDA refused shipment SCS-7544364-9/11/1 from Apotex Corp. (United States) on November 6, 2019. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 6, 2019
Country
United States
Product Category
Drugs and Biologics
Product Code
61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
Charges
75

Recent inspections

  • 738828 (VAI Wed Aug 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-3885306-2/10002/1 (Fri Apr 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1232019-2/20003/1 (Tue Dec 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-5212840-5/10003/1 (Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-5212840-5/20003/1 (Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9760033-4/31/2 (Thu Jul 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources